U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core Biopsy, Surgical Biopsy, Skin Biopsy/Punch Biopsy, Others), By Cause (Application), By Site (Organ), And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Cause (Application)
                       1.2.3. Site (Organ)
                   1.3. Estimates and Forecast Timeline
                   1.4. Research Methodology
                   1.5. Information Procurement
                       1.5.1. Purchased Database
                       1.5.2. GVR’s Internal Database
                       1.5.3. Secondary Sources
                       1.5.4. Primary Research
                   1.6. Information Analysis
                       1.6.1. Data Analysis Models
                   1.7. Market Formulation & Data Visualization
                   1.8. Model Details
                       1.8.1. Commodity Flow Analysis
                   1.9. List of Secondary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Cancer Biopsy Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                   3.3. Business Environment Analysis
                       3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                           3.3.1.1. Supplier Power
                           3.3.1.2. Buyer Power
                           3.3.1.3. Substitution Threat
                           3.3.1.4. Threat of New Entrants
                           3.3.1.5. Competitive Rivalry
                       3.3.2. PESTLE Analysis
Chapter 4. U.S. Cancer Biopsy Market: Type Business Analysis
                   4.1. Type Market Share, 2024 & 2030
                   4.2. Type Segment Dashboard
                   4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Billion)
                   4.4. Fine-needle Aspiration
                       4.4.1. Fine-needle Aspiration Market, 2018 - 2030 (USD Billion)
                       4.4.2. Pharma-use
                           4.4.2.1. Pharma-use Market, 2018 - 2030 (USD Billion)
                       4.4.3. Clinical
                           4.4.3.1. Clinical Market, 2018 - 2030 (USD Billion)
                   4.5. Core Biopsy
                       4.5.1. Core Biopsy Market, 2018 - 2030 (USD Billion)
                       4.5.2. Pharma-use
                           4.5.2.1. Pharma-use Market, 2018 - 2030 (USD Billion)
                       4.5.3. Clinical
                           4.5.3.1. Clinical Market, 2018 - 2030 (USD Billion)
                   4.6. Surgical Biopsy
                       4.6.1. Surgical Biopsy Market, 2018 - 2030 (USD Billion)
                       4.6.2. Pharma-use
                           4.6.2.1. Pharma-use Market, 2018 - 2030 (USD Billion)
                       4.6.3. Clinical
                           4.6.3.1. Clinical Market, 2018 - 2030 (USD Billion)
                   4.7. Skin Biopsy /Punch Biopsy
                       4.7.1. Skin Biopsy /Punch Biopsy Market, 2018 - 2030 (USD Billion)
                       4.7.2. Pharma-use
                           4.7.2.1. Pharma-use Market, 2018 - 2030 (USD Billion)
                       4.7.3. Clinical
                           4.7.3.1. Clinical Market, 2018 - 2030 (USD Billion)
                   4.8. Others
                       4.8.1. Others Market, 2018 - 2030 (USD Billion)
                       4.8.2. Pharma-use
                           4.8.2.1. Pharma-use Market, 2018 - 2030 (USD Billion)
                       4.8.3. Clinical
                           4.8.3.1. Clinical Market, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Cancer Biopsy Market: Cause (Application) Business Analysis
                   5.1. Cause (Application) Market Share, 2024 & 2030
                   5.2. Cause (Application) Segment Dashboard
                   5.3. Market Size & Forecasts and Trend Analysis, by Cause (Application), 2018 to 2030 (USD Billion)
                   5.4. Screening & Monitoring
                       5.4.1. Screening & Monitoring Market, 2018 - 2030 (USD Billion)
                   5.5. Diagnostics
                       5.5.1. Diagnostics Market, 2018 - 2030 (USD Billion)
                   5.6. Investigational & Translational Research
                       5.6.1. Investigational & Translational Research Market, 2018 - 2030 (USD Billion)
                   5.7. Pharma & Biopharma Discovery & Development
                       5.7.1. Pharma & Biopharma Discovery & Development Market, 2018 - 2030 (USD Billion)
Chapter 6. U.S. Cancer Biopsy Market: Site (Organ) Business Analysis
                   6.1. Site (Organ) Market Share, 2024 & 2030
                   6.2. Site (Organ) Segment Dashboard
                   6.3. Market Size & Forecasts and Trend Analysis, by Site (Organ), 2018 to 2030 (USD Billion)
                   6.4. Liver
                       6.4.1. Liver, 2018 - 2030 (USD Billion)
                   6.5. Breast
                       6.5.1. Breast Market, 2018 - 2030 (USD Billion)
                   6.6. Thyroid
                       6.6.1. Thyroid Market, 2018 - 2030 (USD Billion)
                   6.7. Prostate Gland
                       6.7.1. Prostate Gland Market, 2018 - 2030 (USD Billion)
                   6.8. Uterus & Cervix
                       6.8.1. Uterus & Cervix Market, 2018 - 2030 (USD Billion)
                   6.9. Kidney
                       6.9.1. Kidney Market, 2018 - 2030 (USD Billion)
                   6.10. Bladder
                       6.10.1. Bladder Market, 2018 - 2030 (USD Billion)
                   6.11. Lungs
                       6.11.1. Lungs Market, 2018 - 2030 (USD Billion)
                   6.12. Pancreas
                       6.12.1. Pancreas Market, 2018 - 2030 (USD Billion)
                   6.13. Others
                       6.13.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Participant Overview
                   7.2. Company Market Position Analysis
                   7.3. Company Categorization
                   7.4. Strategy Mapping
                   7.5. Company Profiles/Listing
                       7.5.1. BD (Becton, Dickinson and Company)
                           7.5.1.1. Overview
                           7.5.1.2. Financial Performance
                           7.5.1.3. Type Benchmarking
                           7.5.1.4. Strategic Initiatives
                       7.5.2. IZI Medical Products
                           7.5.2.1. Overview
                           7.5.2.2. Financial Performance
                           7.5.2.3. Type Benchmarking
                           7.5.2.4. Strategic Initiatives
                       7.5.3. Johnson & Johnson Services, Inc.
                           7.5.3.1. Overview
                           7.5.3.2. Financial Performance
                           7.5.3.3. Type Benchmarking
                           7.5.3.4. Strategic Initiatives
                       7.5.4. Argon Medical Devices
                           7.5.4.1. Overview
                           7.5.4.2. Financial Performance
                           7.5.4.3. Type Benchmarking
                           7.5.4.4. Strategic Initiatives
                       7.5.5. SPECTRA MEDICAL DEVICES, LLC
                           7.5.5.1. Overview
                           7.5.5.2. Financial Performance
                           7.5.5.3. Type Benchmarking
                           7.5.5.4. Strategic Initiatives
                       7.5.6. Medtronic
                           7.5.6.1. Overview
                           7.5.6.2. Financial Performance
                           7.5.6.3. Type Benchmarking
                           7.5.6.4. Strategic Initiatives
                       7.5.7. Boston Scientific Corporation
                           7.5.7.1. Overview
                           7.5.7.2. Financial Performance
                           7.5.7.3. Type Benchmarking
                           7.5.7.4. Strategic Initiatives
                       7.5.8. CONMED Corporation
                           7.5.8.1. Overview
                           7.5.8.2. Financial Performance
                           7.5.8.3. Type Benchmarking
                           7.5.8.4. Strategic Initiatives
                       7.5.9. INRAD, Inc.
                           7.5.9.1. Overview
                           7.5.9.2. Financial Performance
                           7.5.9.3. Type Benchmarking
                           7.5.9.4. Strategic Initiatives
                       7.5.10. Thermo Fisher Scientific Inc.
                           7.5.10.1. Overview
                           7.5.10.2. Financial Performance
                           7.5.10.3. Type Benchmarking
                           7.5.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. cancer biopsy market, by type, 2018 - 2030 (USD Billion)
Table 4. U.S. cancer biopsy market, by cause (application), 2018 - 2030 (USD Billion)
Table 5. U.S. cancer biopsy market, by site (organ), 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 U.S. cancer biopsy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type outlook (USD Billion)
Fig. 10 Cause (application) outlook (USD Billion)
Fig. 11 Site (organ) outlook (USD Billion)
Fig. 12 Competitive landscape
Fig. 13 U.S. cancer biopsy market dynamics
Fig. 14 U.S. cancer biopsy market: Porter’s five forces analysis
Fig. 15 U.S. cancer biopsy market: PESTLE analysis
Fig. 16 U.S. cancer biopsy market: Type segment dashboard
Fig. 17 U.S. cancer biopsy market: Type market share analysis, 2024 & 2030
Fig. 18 Fine-needle aspiration market, 2018 - 2030 (USD Billion)
Fig. 19 Pharma-use market, 2018 - 2030 (USD Billion)
Fig. 20 Clinical market, 2018 - 2030 (USD Billion)
Fig. 21 Core biopsy market, 2018 - 2030 (USD Billion)
Fig. 22 Pharma-use market, 2018 - 2030 (USD Billion)
Fig. 23 Clinical market, 2018 - 2030 (USD Billion)
Fig. 24 Surgical biopsy market, 2018 - 2030 (USD Billion)
Fig. 25 Pharma-use market, 2018 - 2030 (USD Billion)
Fig. 26 Clinical market, 2018 - 2030 (USD Billion)
Fig. 27 Skin biopsy /punch biopsy market, 2018 - 2030 (USD Billion)
Fig. 28 Pharma-use market, 2018 - 2030 (USD Billion)
Fig. 29 Clinical market, 2018 - 2030 (USD Billion)
Fig. 30 Others market, 2018 - 2030 (USD Billion)
Fig. 31 Pharma-use market, 2018 - 2030 (USD Billion)
Fig. 32 Clinical market, 2018 - 2030 (USD Billion)
Fig. 33 U.S. cancer biopsy market: Cause (application) segment dashboard
Fig. 34 U.S. cancer biopsy market: Cause (application) market share analysis, 2024 & 2030
Fig. 35 Screening & monitoring market, 2018 - 2030 (USD Billion)
Fig. 36 Diagnostics market, 2018 - 2030 (USD Billion)
Fig. 37 Investigational & translational research market, 2018 - 2030 (USD Billion)
Fig. 38 Pharma & biopharma discovery & development market, 2018 - 2030 (USD Billion)
Fig. 39 U.S. cancer biopsy market: Site (organ) segment dashboard
Fig. 40 U.S. cancer biopsy market: Site (organ) market share analysis, 2024 & 2030
Fig. 41 Liver market, 2018 - 2030 (USD Billion)
Fig. 42 Breast market, 2018 - 2030 (USD Billion)
Fig. 43 Thyroid market, 2018 - 2030 (USD Billion)
Fig. 44 Prostate gland market, 2018 - 2030 (USD Billion)
Fig. 45 Uterus & cervix market, 2018 - 2030 (USD Billion)
Fig. 46 Kidney market, 2018 - 2030 (USD Billion)
Fig. 47 Bladder market, 2018 - 2030 (USD Billion)
Fig. 48 Lungs market, 2018 - 2030 (USD Billion)
Fig. 49 Pancreas market, 2018 - 2030 (USD Billion)
Fig. 50 Others market, 2018 - 2030 (USD Billion)
Fig. 51 Company categorization
Fig. 52 Company market position analysis
Fig. 53 Strategic framework